HIV-specific CD4+Th17 cells from HIV infected long-term non-progressors exhibit lower CTLA-4 expression and reduced apoptosis

Immunobiology. 2018 Nov;223(11):658-662. doi: 10.1016/j.imbio.2018.07.011. Epub 2018 Jul 6.

Abstract

Progressive HIV infection is marked with reduced frequency and impaired function of Th17 cells. Since T-cell functional responses are regulated by various inhibitory receptors; we examined the expression profile of CTLA-4, PD-1, Tim-3 and apoptotic marker: Caspase-3 on virus-specific Th17 cells from HIV-infected Long-Term Non-Progressors (LTNPs), chronic disease progressors and HIV-uninfected healthy controls (HC) using flowcytometry. Real-time PCR was done to analyze the mRNA expression of Th17 and Treg specific genes. LTNPs showed higher frequencies of HIV-specific Th17 cells; higher mRNA expression of IL-17, IL-22 while lower expression of IL-10; along with lower Caspase-3 expression than the progressors. Among inhibitory receptors, expression of CTLA-4 was 27 and 8 fold; PD-1 was 8 and 6 fold while Tim-3 was 7 and 6 fold higher in progressors and LTNPs respectively than HC. Among HIV-infected patients, LTNPs had 3-fold lower expression of CTLA-4 on HIV-specific Th17 cells than progressors (p = 0.06). Caspase-3+ve Th17 cells were associated with HIV-specific Th17 cells expressing CTLA-4 (r = 0.66;p < 0.0001), PD-1 (r = 0.40;p = 0.02) and Tim-3 (r = 0.35;p = 0.04). To conclude, virus-specific Th17 cells from LTNP maintained IL-17 production, expressed low levels of CTLA-4 and reduced apoptosis. The study suggests that such functional competence of Th17 cells could be one of the factors in maintenance of non-progressive HIV infection.

Keywords: Apoptosis; CTLA-4; Exhaustion; HIV; LTNP; Th17.

Publication types

  • Comparative Study

MeSH terms

  • Apoptosis
  • CD4 Antigens / metabolism
  • CTLA-4 Antigen / genetics
  • CTLA-4 Antigen / metabolism*
  • Caspase 3 / genetics
  • Caspase 3 / metabolism
  • Cells, Cultured
  • Chronic Disease
  • Cross-Sectional Studies
  • Disease Progression
  • Follow-Up Studies
  • HIV Infections / immunology*
  • HIV Long-Term Survivors
  • HIV-1 / physiology*
  • Hepatitis A Virus Cellular Receptor 2 / genetics
  • Hepatitis A Virus Cellular Receptor 2 / metabolism
  • Humans
  • Interleukin-17 / genetics
  • Interleukin-17 / metabolism
  • T-Lymphocytes, Regulatory / immunology*
  • Th17 Cells / immunology*

Substances

  • CD4 Antigens
  • CTLA-4 Antigen
  • HAVCR2 protein, human
  • Hepatitis A Virus Cellular Receptor 2
  • Interleukin-17
  • Caspase 3